Mineralocorticoid receptor function in major depression

Archives of General Psychiatry

Volumn 60, Issue 1, 2003, Pages 24-28

  Young, Elizabeth A ^a   Lopez, Juan F ^a   Murphy Weinberg, Virginia ^a   Watson, Stanley J ^a   Akil, Huda ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; SEROTONIN RECEPTOR; SPIRONOLACTONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DEPRESSION; FEMALE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEGATIVE FEEDBACK; SEROTONINERGIC SYSTEM;

EID: 0037227044     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.60.1.24     Document Type: Article

References (45)

1. deKloet R, Wallach G, McEwen BS: Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology. 1975;96:598-605.
2. Reul JMH, deKloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 1985;117:2505-2511.
3. Spencer RL, Young EA, Choo PH, McEwen BS. Glucocorticoid type I and type II receptor binding: estimates of in vivo receptor number, occupancy and activation with varying levels of steroid. Brain Res. 1990;514:37-48.
4. McEwen BS, Weiss JM, Schwartz LS. Selective retention of corticosterone by limbic structures in the rat brain. Nature. 1968;220:911-913.
5. Herman JP, Patel PD, Akil H, Watson S. Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol Endocrinol. 1989;3:1886-1894.
6. Patel PD, López JF, Lyons DM, Burke S, Wallace M, Schatzberg AF. Glucocortioid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiatr Res. 2000;34:383-392.
7. Ratka A, Sutanto W, Bloemers M, de Kloet ER. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology. 1989;50:117-123.
8. Oitzl MS, van Haarst AD, Sutanto W, de Kloet ER. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis. Psychoneuroendocrinology. 1995;20:655-675.
9. Gesing A, Bilang-Bleuel A, Droste SK, Linthorst AC, Holsboer F, Reul JM. Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone. J Neurosci. 2001;21:4822-4829.
10. Dallman MF, Levin N, Cascio CS, Akana SF, Jacobsen L, Kuhn RW. Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via type I corticosterone-preferring receptors. Endocrinology. 1989;124:2844-2850.
11. Sapolsky RM, Armanini MP, Packan DR, Sutton SW, Plotsky PM. Glucocorticold feedback inhibition of adrenocorticotropic hormone secretagogue release: relationship to corticosteroid receptor occupancy in various limbic sites. Neuroendocrinology. 1990;51:328-336.
12. Young EA, Haskett RF, Grunhaus L, Pande A, Weinberg VM, Watson SJ, Akil H. Increased circadian activation of the hypothalamic pituitary adrenal axis in depressed patients in the evening. Arch Gen Psychiatry. 1994;51:701-707.
13. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H. Normal pituitary response to metyrapone in the morning in depressed patients: implications for circadian regulation of CRH secretion. Biol Psychiatry. 1997;41:1149-1155.
14. Bradbury MJ, Akana SF, Dallman MF. Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation. Endocrinology. 1994;134:1286-1296.
15. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H. The role of mineralocorticoid receptors in HPA axis regulation in humans. J Clin Endocrinol Metab. 1998;83:3339-3345.
16. Halbreich U, Asnis GM, Schindledecker R, Zurnoff B, Nathan RS. Cortisol secretion in endogenous depression, I: basal plasma levels. Arch Gen Psychiatry. 1985;2:909-914.
17. Pfohl B, Sherman B, Schlecter J, Stone R. Pituitary/adrenal axis rhythm disturbances in psychiatric patients. Arch Gen Psychiatry. 1985;42:897-903.
18. Linkowski P, Mendlewicz J, Leclercq R, Brasseur M, Hubain P, Golstein J, Copinschi G, Van Cauter E. The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab. 1985;61:429-438.
19. Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett N. Neuroendocrine aspects of primary endogenous depression, I: cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry. 1987;44:328-336.
20. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, Jams N, Kronfol Z, Lohr N, Steiner M, DeVigne JP, Young EA. A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Arch Gen Psychiatry. 1981;38:15-22.
21. Young EA, Kotun J, Haskett RF, Grunhaus L, Greden JF, Watson SJ, Akil H. Dissociation between pituitary and adrenal suppression to dexamethasone in depression. Arch Gen Psychiatry. 1993;50:395-403.
22. Lopez JF, Chalmers DT, Little KY, Watson SJ. Regulation of serotonin 1a, glucocorticoid and mineralocorticoid receptors in rat and human hippocampu: implications for the neurobiology of depression. Biol Psychiatry. 1998;43:547-573.
23. Trapp T, Holsboer F. Heterodimerization between mineralocorticoid and glucocorticoid receptors increases the functional diversity of corticosteroid action. Trends Pharmacol Sci. 1996;17:145-149.
24. Lopez JF, Vázquez DM, Chalmers DT, Akil H, Watson SJ. Regulation of 5-HT receptors and the hypothalamic-pituitary-adrenal axis: implications for the neurobiology of suicide. Ann N YAcad Sci. 1997;836:106-134.
25. de Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev. 1998;19:269-301.
26. Joels M, de Kloet ER. Mineralocorticoid and glucocorticoid receptors in the brain: implications for ion permeability and transmitter systems. Prog Neurobiol. 1994;43:1-36.
27. Kuroda Y, Watanabe Y, Albeck DS, Hastings NB, McEwen BS. Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on 5-HT1A and 5-HT2 receptor binding and 5-HT transporter mRNA expression in rat brain. Brain Res. 1994;648:157-161.
28. Meijer OC, de Kloet ER. Corticosterone suppresses the expression of 5-HT1A receptor mRNA in rat dentate gyrus. Eur J Pharmacol. 1994;266:255-261.
29. Karten YJ, Nair SM, van Essen L, Sibug R, Joels M. Long-term exposure to high corticosterone levels attenuates serotonin responses in rat hippocampal CA1 neurons. Proc Natl Acad Sci U S A. 1999;96:13456-13461.
30. Kuroda Y, Mikuni M, Ogawa T, Takahashi K. Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors. Psychopharmacology. 1992;108:27-32.
31. Kuroda Y, Mikuni M, Nomura N, Takahashi K. Differential effect of subchronic dexamethasone treatment on serotonin-2 and β-adrenergic receptors in the rat cerebral cortex and hippocampus. Neurosci Lett. 1993;155:195-198.
32. McKittrick CR, Blanchard DC, Blanchard RJ, McEwen BS, Sakai RR. Serotonin receptor binding in a colony model of chronic social stress. Biol Psychiatry. 1995;37:383-396.
33. Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S, Chen JJ, Mann JJ. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology. 2001;25:892-903.
34. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry. 1999;46:1375-1387.
35. Drevets WC, Frank E, Price JC, Kupfer DJ, Greer PJ, Mathis C. Serotonin type-1A receptor imaging in depression. Nucl Med Biol. 2000;27:499-507.
36. 2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry. 1990;47:1038-1047.
37. 2 sites in cortex and amygdala. Brain Res. 1993;614:37-44.
38. Yates M, Leake A, Candy JM, Fairbairn AF, McKeith IG, Ferrier IN. 5HT2 receptor changes in major depression. Biol Psychiatry. 1990;27:489-496.
39. Blier P, de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci. 1994;15:220-226.
40. Welner SA, De Montigny C, Desroches J, Desjardins P, Suranyi-Cadotte BE. Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment. Synapse. 1989;4:347-352.
41. Klimek V, Zak-Knapik J, Mackowiak M. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain. J Psychiatry Neurosci. 1994;19:63-67.
42. Peroutka SJ, Snyder SH. Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline. J Pharmacol Exp Ther. 1980;215:582-587.
43. Schreiber R, De Vry J. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat. Eur J Pharmacol. 1993;249:341-351.
44. Berendsen HH. Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans? Pharmacol Ther. 1995;66:17-37.
45. Borsini F. Balance between cortical 5-HT1A and 5-HT2 receptor function: hypothesis for a faster antidepressant action. Pharmacol Res. 1994;30:1-11.